Abstract:Noroviruses are the leading cause of acute gastroenteritis, and they can affect humans of all age groups. In immunocompromised patients, norovirus infections can develop into chronic diarrhea or show prolonged asymptomatic virus shedding. Chronic norovirus infections are frequently reported for solid organ transplant recipients, with rapid intrahost norovirus evolution seen. In this report, we describe a case of chronic norovirus infection in an immunocompromised patient who was followed up for over 5 years. The purpose of the study was to specify the norovirus evolution in a chronically infected immunocompromised host and identify possible selection sites in norovirus capsid protein. During the follow-up period, 25 sequential stool samples were collected and nine of them were selected to generate amplicons covering viral RNA-dependent RNA polymerase (RdRp) and viral capsid protein (VP1) genes. Amplicons were sequenced using next-generation sequencing. Single nucleotide polymorphisms were defined, which demonstrated a nearly 3-fold greater mutation rate in the VP1 genome region compared to the RdRp genome region (7.9 vs. 2.8 variable sites/100 nucleotides, respectively). This indicates that mutations in the virus genome were not accumulated randomly, but are rather the result of mutant selection during the infection cycle. Using ShoRAH software we were able to reconstruct haplotypes occurring in each of the nine selected samples. The deduced amino-acid haplotype sequences were aligned and the positions were analyzed for selective pressure using the Datamonkey program. Only 12 out of 25 positive selection sites were within the commonly described epitopes A, B, C, and D of the VP1 protein. New positive selection sites were determined that have not been described before and might reflect adaptation of the norovirus toward optimal histo-blood-group antigen binding, or modification of the norovirus antigenic properties. These data provide new insights into norovirus evolutionary dynamics and indicate new putative epitope "hot-spots" of modified and optimized norovirus-host interactions.

Replication in Human Intestinal Enteroids of Infectious Norovirus from Vomit Samples

Vomiting as a Symptom and Transmission Risk in Norovirus Illness: Evidence from Human Challenge Studies

Human Norovirus Replication in Human Intestinal Enteroids as Model to Evaluate Virus Inactivation

Human norovirus targets enteroendocrine epithelial cells in the small intestine

Human Norovirus Detection and Production, Quantification, and Storage of Virus‐Like Particles

Intra- and Inter-host Evolution of Human Norovirus in Healthy Adults

Replication of Human Norovirus in Human Intestinal Enteroids Is Affected by Fecal Sample Processing

Replication of Norovirus in Cell Culture Reveals a Tropism for Dendritic Cells and Macrophages

Phylogenetic Investigation of Norovirus Transmission between Humans and Animals

Human Norovirus Efficiently Replicates in Differentiated 3D-Human Intestinal Enteroids

A household survey of intrafamily norovirus transmission

Persistence of human norovirus RT-qPCR signals in simulated gastric fluid

Norovirus GII.4 Detection in Environmental Samples from Patient Rooms during Nosocomial Outbreaks

Infectious Norovirus Is Chronically Shed by Immunocompromised Pediatric Hosts

Capturing norovirus transmission

Sources of Airborne Norovirus in Hospital Outbreaks

Bile acids and ceramide overcome the entry restriction for GII.3 human norovirus replication in human intestinal enteroids

Intrahost Norovirus Evolution in Chronic Infection Over 5 Years of Shedding in a Kidney Transplant Recipient

A Decade of Chronic Norovirus Infection Surveillance at the NIH Clinical Research Center: Clinical Characteristics, Molecular Epidemiology, and Replication

Viral intra-host evolution in immunocompetent children contributes to human norovirus diversification at the global scale